{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.3616.200.110.102.3099","meta":{"versionId":"5","lastUpdated":"2020-08-18T10:21:27.000-04:00"},"text":{"status":"generated","div":"<div xmlns=\"http://www.w3.org/1999/xhtml\">\n      <h2>COVID19 ICD10CM Value Set for Scleroderma (Systemic Sclerosis)</h2>\n      <p>This value set includes codes from the following code systems:</p>\n      <ul>\n        <li>Include these codes as defined in \n          <code>http://hl7.org/fhir/sid/icd-10-cm</code>\n          <table class=\"none\">\n            <tr>\n              <td>\n                <b>Code</b>\n              </td>\n              <td>\n                <b>Display</b>\n              </td>\n            </tr>\n            <tr>\n              <td>D86.85</td>\n              <td>Sarcoid myocarditis</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>M34</td>\n              <td>Systemic sclerosis [scleroderma]</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>M34.0</td>\n              <td>Progressive systemic sclerosis</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>M34.1</td>\n              <td>CR(E)ST syndrome</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>M34.2</td>\n              <td>Systemic sclerosis induced by drug and chemical</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>M34.8</td>\n              <td>Other forms of systemic sclerosis</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>M34.81</td>\n              <td>Systemic sclerosis with lung involvement</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>M34.82</td>\n              <td>Systemic sclerosis with myopathy</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>M34.83</td>\n              <td>Systemic sclerosis with polyneuropathy</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>M34.89</td>\n              <td>Other systemic sclerosis</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>M34.9</td>\n              <td>Systemic sclerosis, unspecified</td>\n              <td/>\n            </tr>\n          </table>\n        </li>\n      </ul>\n    </div>"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3616.200.110.102.3099","version":"20200721","name":"COVID19 ICD10CM Value Set for Scleroderma (Systemic Sclerosis)","status":"active","date":"2020-07-21T01:00:30-04:00","publisher":"Clinical Architecture","compose":{"include":[{"system":"http://hl7.org/fhir/sid/icd-10-cm","concept":[{"code":"D86.85","display":"Sarcoid myocarditis"},{"code":"M34","display":"Systemic sclerosis [scleroderma]"},{"code":"M34.0","display":"Progressive systemic sclerosis"},{"code":"M34.1","display":"CR(E)ST syndrome"},{"code":"M34.2","display":"Systemic sclerosis induced by drug and chemical"},{"code":"M34.8","display":"Other forms of systemic sclerosis"},{"code":"M34.81","display":"Systemic sclerosis with lung involvement"},{"code":"M34.82","display":"Systemic sclerosis with myopathy"},{"code":"M34.83","display":"Systemic sclerosis with polyneuropathy"},{"code":"M34.89","display":"Other systemic sclerosis"},{"code":"M34.9","display":"Systemic sclerosis, unspecified"}]}]}}